Drug products
-
Thallous Chloride Tl 201
Active Ingredient LIRAGLUTIDE RECOMBINANT Proprietary Name SAXENDA Applicant NOVO Dosage Form;Route SUBCUTANEOUS Strength 18MG/3ML (6MG/ML) Application Type N Product Number 1 Approval Date 2014/12/23 RX/OTC/DISCN Yes Applicant Full Name RX
FDA's Approved Drug Products database
